Drugs / etiprednol dicloacetate
etiprednol dicloacetate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00035503 | Jan 2002 → Jan 2004 | Crohn disease | Teva Branded Pharmaceutical Products R&D, Inc. | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | etiprednol dicloacetate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00035503 ↗ |
| Known as | BNP-166 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2107614 ↗ |
| Known as | Dicloacetate d'etiprednol | ChEMBL registry synonym — accepted as the source's own label CHEMBL2107614 ↗ |
| Known as | Dicloroacetato de etiprednol | ChEMBL registry synonym — accepted as the source's own label CHEMBL2107614 ↗ |
| Modality | Small molecule | — CHEMBL2107614 ↗ |